Concepedia

Author

Deqiang Kong

East China Normal UniversityORCID

Also Known As

D Q Kong, Deqiang Kong, Hanah B. Robertson, Robertson, Hanah

49

Publications

598

Citations

12

H-Index

32

Concepts

All Affiliations

East China Normal UniversityZhejiang UniversitySecond Affiliated Hospital of Zhejiang UniversityTongji HospitalTongji University
DK

About

Deqiang Kong is an author at East China Normal University specializing in molecular biology, cell biology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

2

2

171

2

Medicine

2

2

40

3

Health Sciences

1

1

27

4

Natural Sciences

1

1

29

5

Biomedical Engineering

1

1

22

Deqiang Kong

×

12

Publications

496

Citations

12

H-Index

YearCitations

A small and highly sensitive red/far-red optogenetic switch for applications in mammals

Yang Zhou, Deqiang Kong, Xinyi Wang,

Nature Biotechnology

2021

144

Liquid-liquid phase separation of light-inducible transcription factors increases transcription activation in mammalian cells and mice

Nils Schneider, Franz-Georg Wieland, Deqiang Kong,

Science Advances

2021

124

A far-red light–inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation

Xinyi Wang, Kaili Dong, Deqiang Kong,

Science Advances

2021

39

A programmable protease-based protein secretion platform for therapeutic applications

Xinyi Wang, Liping Kang, Deqiang Kong,

Nature Chemical Biology

2023

29

Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics

Longliang Qiao, Lingxue Niu, Zhihao Wang,

Nature Cancer

2025

27

Bromo‐ and extraterminal domain protein inhibition improves immunotherapy efficacy in hepatocellular carcinoma

Chen Liu, Xiaolong Miao, Yao Wang,

Cancer Science

2020

24

The dynamic cellular landscape of grafts with acute rejection after heart transplantation

Deqiang Kong, Siyuan Huang, Xiaolong Miao,

The Journal of Heart and Lung Transplantation

2022

22

A sensitive red/far-red photoswitch for controllable gene therapy in mouse models of metabolic diseases

Longliang Qiao, Lingxue Niu, Meiyan Wang,

Nature Communications

2024

21

Tadalafil enhances the therapeutic efficacy of BET inhibitors in hepatocellular carcinoma through activating Hippo pathway

Deqiang Kong, Yuancong Jiang, Xiaolong Miao,

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

2021

18

BET protein inhibition evidently enhances sensitivity to PI3K/mTOR dual inhibition in intrahepatic cholangiocarcinoma

Xiaolong Miao, Chen Liu, Yuancong Jiang,

Cell Death and Disease

2021

17

Page 1